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INTRODUCTION: The bone–cartilage interface 
in an articulating joint is a biomechanically 
important region where calcified cartilage forms an 
intersection between the hyaline cartilage and 
subchondral bone. It is prone to fracture and may 
undergo abnormal thickening, which can lead to 
progression of osteoarthritis1. A biologically and 
mechanically stable bone-cartilage interface as part 
of an osteochondral scaffold can thus have 
considerable clinical relevance. In this study, we 
have reported on a porous 3D printed polylactic 
acid (PLA)/collagen hybrid scaffold as a junction 
between bone-cartilage and preliminary in vitro 
evaluation results such as biocompatibility and 
mechanical properties are presented. 
 
METHODS: The PLA biopolymer scaffold was 
fabricated by a 3D printing technique that runs on 
fused deposition modelling (FDM) technology by 
heating and extruding thermoplastic filament. The 
scaffold has a unit cell size of 0.5 mm. The PLA 
scaffold was subjected to 10 minutes UV 
processing in a UV/ozone reactor to improve its 
surface wettability. Then, collagen was filtered into 
the porous structure to obtain PLA/collagen hybrid 
scaffold. Sheep bone marrow mesenchymal stem 
cells (BMMSCs) were used to assess the cell 
morphology, viability, proliferation and 
differentiation on these PLA/collagen scaffolds. 
Live/Dead and Alamar Blue assays were used to 
examine viability and proliferation. Scanning 
electron microscopy (SEM) and immunostaining 
were used to look at cell morphology. Osteogenic 
and chondrogenic differentiation of BMMSCs 
were also investigated. The mechanical stability of 
scaffolds was evaluated using compression testing. 
RESULTS: It was shown that the 3D printed PLA 
scaffolds support cell viability (Fig.1) and 
proliferation throughout 28 days. The design of the 
scaffold affected cell attachment and proliferation. 
Well-developed actin cytoskeleton was shown by 
immunostaining, and cell spreading was confirmed 
by SEM (Fig.1). It was also confirmed that the 
scaffolds supported osteogenic and chondrogenic 
differentiation of BMMSCs. Compressive modulus 
and strengths of these scaffolds were 11MPa and 
3.4MPa, respectively. 
 
Fig. 1: Biocompatibility of the developed PLA 
hybrid scaffolds: Live/Dead assay - green shows 
viability of cells on day 14 (left); SEM micrograph 
shows cell bridging between two layers of the 3D 
printed scaffold (right) 
 
DISCUSSION & CONCLUSIONS: It has been 
shown that the developed 3D printed PLA hybrid 
scaffolds have the potential to be used for bone-
cartilage interface tissue engineering. They are 
biocompatible, with the potential to provide 
substrate for chondro- and osteogenic 
differentiation of stem cells. These scaffolds can be 
produced inexpensively and be tailored specifically 
to patients. 
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